Intra-anal and rectal application of L-erythro methoxamine gel increases anal resting pressure in healthy volunteers

British Journal of Surgery

Volumn 92, Issue 12, 2005, Pages 1539-1545

  Nisar, P J ^a   Gruss, H J ^b,c   Bush, D ^a   Barras, N ^c   Acheson, A G ^a   Scholefield, J H ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b Department of Geriatrics   (Germany)

^c Keaton House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; LEVO ERYTHROMETHOXAMINE; NIFEDIPINE; UNCLASSIFIED DRUG;

ADULT; ANORECTAL PRESSURE; ANUS SPHINCTER DISORDER; ARTICLE; BLADDER IRRITATION; BLOOD SAMPLING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; FUNCTIONAL ASSESSMENT; GEL; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INCONTINENCE; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PULSE RATE; REFLEX; SIDE EFFECT; SWEATING; SYSTOLIC BLOOD PRESSURE; VOMITING;

ADMINISTRATION, RECTAL; ADRENERGIC ALPHA-AGONISTS; ADULT; ANAL CANAL; BLOOD PRESSURE; FEMALE; GELS; HUMANS; MALE; MANOMETRY; METHOXAMINE; MIDDLE AGED; PRESSURE; PULSE; SINGLE-BLIND METHOD;

EID: 28944441656     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5171     Document Type: Article

References (28)

1. Lestar B, Penninckx F, Kerremans R. The composition of anal basal pressure. An in vivo and in vitro study in man. Int J Colorectal Dis 1989; 4: 118-122.
2. Frenckner B, Euler CV. Influence of pudendal block on the function of the anal sphincters. Gut 1975; 16: 482-489.
3. Engel AF, Kamm MA, Bartram CI, Nicholls RJ. Relationship of symptoms in faecal incontinence to specific sphincter abnormalities. Int J Colorectal Dis 1995; 10: 152-155.
4. Chang SC, Lin JK. Change in anal continence after surgery for intersphincteral anal fistula: a functional and manometric study. Int J Colorectal Dis 2003; 18: 111-115.
5. Snooks S, Henry MM, Swash M. Faecal incontinence after anal dilatation. Br J Surg 1984; 71: 617-618.
6. Vaizey CJ, Kamm MA, Bartram CI. Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence. Lancet 1997; 349: 612-615.
7. Sun WM, Read NW, Donnelly TC. Impaired internal anal sphincter in a subgroup of patients with idiopathic fecal incontinence. Gastroenterology 1989; 97: 130-135.
8. Sun WM, Read NW, Miner PB, Kerrigan DD, Donnelly TC. The role of transient internal sphincter relaxation in faecal incontinence? Int J Colorectal Dis 1990; 5: 31-36.
9. Farouk R, Duthie GS, Pryde A, McGregor AB, Bartolo DC. Internal anal sphincter dysfunction in neurogenic faecal incontinence. Br J Surg 1993; 80: 259-261.
10. Carlstedt A, Fasth S, Hulten L, Nordgren S. The sympathetic innervation of the internal anal sphincter and rectum in the cat. Acta Physiol Scand 1988; 133: 423-431.
11. Shibamoto T, Chakder S, Rattan S. Role of hypogastric nerve activity in opossum internal anal sphincter function: influence of surgical and chemical denervation. J Pharmacol Exp Ther 1994; 271: 277-284.
12. Frenckner B, Ihre T. Influence of autonomic nerves on the internal anal sphincter in man. Gut 1976; 17: 306-312.
13. Penninckx F, Kerremans R, Beckers J. Pharmacological characteristics of the non-striated anorectal musculature in cats. Gut 1973; 14: 393-398.
14. Gutierrez JG, Shah AN. Autonomic control of the internal anal sphincter in man. In International Symposium of Gastrointestinal Motility, von Trappen G (ed.). Typoff Press: Leuven, 1975; 363-373.
15. Yamato S, Rattan S. Role of alpha adrenoceptors in opossum internal anal sphincter. J Clin Invest 1990; 86: 424-429.
16. Parks AG, Fishlock DJ, Cameron JD, May H. Preliminary investigation of the pharmacology of the human internal anal sphincter. Gut 1969; 10: 674-677.
17. Friedmann CA. The action of nicotine and catecholamines on the human internal anal sphincter. Am J Dig Dis 1968; 13: 428-431.
18. Speakman CT, Hoyle CH, Kamm MA, Henry MM, Nicholls RJ, Burnstock G. Adrenergic control of the internal anal sphincter is abnormal in patients with idiopathic faecal incontinence. Br J Surg 1990; 77: 1342-1344.
19. Speakman CT, Hoyle CH, Kamm MM, Henry MM, Nicholls RJ, Burnstock G. Abnormalities of innervation of internal anal sphincter in fecal incontinence. Dig Dis Sci 1993; 38: 1961-1969.
20. Speakman CT, Hoyle CH, Kamm MA, Swash M, Henry MM, Nicholls RJ et al. Abnormal internal anal sphincter fibrosis and elasticity in fecal incontinence. Dir Colon Rectum 1995; 38: 407-410.
21. Carapeti EA, Kamm MA, Evans BK, Phillips RK. Topical phenylephrine increases anal sphincter resting pressure. BrJ Surg 1999; 86: 267-270.
22. Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001; 48: 356-359.
23. Carapeti EA, Kamm MA, Phillips RK. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 2000; 87: 38-42.
24. Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol 1994; 46: 929-936.
25. Jones OM, Thompson JM, Brading AF, Mortensen NJ. L-Erythro-methoxamine is more potent than phenylephrine in effecting contraction of internal anal sphincter in vitro. Br J Surg 2003; 90: 872 -876.
26. Cross SE, Thompson MJ, Roberts MS. Transdermal penetration of vasoconstrictors - present understanding and assessment of the human epidermal flux and retention of free bases and ion-pairs. Pharm Res 2003; 20: 270-274.
27. van Hoogdalem E, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 1991; 21: 11-26.
28. Klutch A, Bordun M. Metabolic fate of methoxamine and n-isopropylmethoxamine. J Med Chem 1967; 10: 861-863.